Specifically, these tumors lack punctate intracellular clustering of the receptor seen in non-neoplastic cells, demonstrating that both the expression and distribution of TrkB.T1 differ in normal brain compared with gliomas, providing a degree of visual specificity and receptor localization that was previously not possible. This evidence concerns the gene NTRK2 and central nervous system cancer.